Search results
Tematy dnia
4 maj 2023 · FDA approval would make donanemab the third new Alzheimer’s treatment in two years. In January, the agency granted accelerated approval to lecanemab, made by Biogen in Cambridge, Massachusetts,...
- FDA Approves Alzheimer's Drug Lecanemab Amid Safety Concerns
The drug, a monoclonal antibody, is infused into a patient...
- Could Drugs Prevent Alzheimer's? These Trials Aim to Find Out
Its trial of the drug crenezumab will finish this year....
- Controversial Alzheimer's Drug Approval Could Affect Other Diseases
Drug-development partners Roche, based in Basel,...
- What Scientists Are Watching
A clinical-trial participant receives an infusion of...
- But is It a Breakthrough
Some researchers are celebrating this week’s announcement...
- This is How an Alzheimer's Gene Ravages The Brain
A neuron (green) from a person with Alzheimer’s disease...
- Neurotechnology
Neurotechnologies that record and alter brain activity could...
- Brain-reading Devices Allow Paralysed People to Talk Using Their Thoughts
Two studies report considerable improvements in technologies...
- FDA Approves Alzheimer's Drug Lecanemab Amid Safety Concerns
17 lip 2023 · Full results about the Alzheimer's disease drug donanemab have been released today, supporting earlier trial results that suggested the breakthrough drug may slow down the progression of the disease.
2 lip 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and...
2 lip 2024 · CHICAGO, July 2, 2024 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to approve Kisunla™ (donanemab, Eli Lilly) for the treatment of people living with early symptomatic Alzheimer’s disease, which includes mild cognitive impairment and the mild dementia stage of Alzheimer’s disease ...
17 lip 2023 · A new drug, donanemab, is being hailed as a turning point in the fight against Alzheimer's, after a global trial confirms it slows cognitive decline. The antibody medicine helps in the early...
11 cze 2024 · On Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed to slow the progression of early...
2 lip 2024 · WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
